Individuals diagnosed with GBM that are IDH-WT- and MGMT-methylated, therefore, have a significantly better prognosis due to increased sensitivity to temozolomide and subsequent radiotherapy [17]. This evidence concerns the gene IDH2 and glioblastoma.